Analyzing nasal swabs taken during the pandemic, researchers at Yale School of Medicine suggest that the frequent presence of other viruses and bacteria may have helped to protect children from the worst effects of COVID-19 by boosting their immune systems.
CSPC to launch Paxlovid version in China; SEC charges ex-Pfizer employee with insider trading
Pfizer inked a deal with a Chinese pharma to launch a form of its Covid-19 antiviral Paxlovid in China. The company is working with CSPC